Lably
Skip to content

Prescription drug addiction

Medical condition

  • 14 min read
  • 7 chapters
Adderall XR 10MG tablets
Ryanaxp at en.Wikipedia · Public domain

Related on Lably

Through Medication, Medical prescription and Mental disorder

Lab · Class 8–12MicroorganismsLab · Class 8Wastewater StoryLab · Class 11NodeMCU & IoT

Prescription drug addiction was recognized as a significant public health and law enforcement problem worldwide in the past decade due to its medical and social consequences. Particularly, the United States declared a public health emergency regarding increased drug overdoses in 2017. Since then, multiple public health organizations have emphasized the importance of prevention, early diagnosis and treatments of prescription drug addiction to address this public health issue.

Causes and risk factors

There are multiple risk factors that can increase the chance of developing drug addiction, including patient factors, nature of drug and over-prescription.

Patient factors

Studies have indicated that adolescents and young adults were particularly vulnerable to prescription drug abuse. People with acute or chronic pain, anxiety disorders and ADHD were at increased risk for addiction comorbidity. History of illicit drug use and substance use disorder were consistently identified as risk factors for prescription drug abuse.

Misuse of opioid analgesics is frequently associated with mental health disorder, including depression, posttraumatic stress disorder, and anxiety disorders. Some risk factors for opioid and benzodiazepine sedatives or tranquilizers addiction are white race, female sex, panic symptoms, other psychiatric symptoms, alcohol and cigarette dependence and history of illicit drug use. Addiction to pharmaceutical stimulants have been predominantly among adolescents and young adults.

Drug characteristics

Patients who have been prescribed medications to treat a health condition or disorder are shown to be more vulnerable to prescription drug abuse and addiction, especially when the prescribed medicine falls into the same drug classes of common illicit drugs. For example, methylphenidate and amphetamines are in the same stimulant category as cocaine and methamphetamine, while hydrocodone and oxycodone are under the opioid category as heroin.

Key pharmacological factors associated with drug addiction include:

  • high frequency of drug use
  • high doses administered
  • rapid rate of onset of action
  • high drug potency
  • co-ingestion of psychoactive substances with similar (eg. sedatives and alcohol) or different pharmacological profiles (eg. stimulants and nicotine) can result in additional reinforcement of addiction.

Over-prescription and doctor shopping

Health practitioners can prescribe drugs in a number of ways that inadvertently and unintentionally contribute to prescription drug abuse. They may inappropriately prescribe drugs due to influence by ill-informed, careless or deceptive patients or by succumbing to patient pressure.

The American Medical Association describes four mechanism by which a physician becomes involved in overprescribing in its four-"Ds" model:

  1. Dated: the physician is outdated regarding knowledge of pharmacology and the differential diagnosis and management of diseases.
  2. Duped: the physician may be vulnerable to a manipulative patient.
  3. Dishonest: a dishonest physician may be motivated to write prescriptions for controlled substances under financial incentives.
  4. Disabled: a physician with medical or psychiatric disability such that they have "loose" standards in prescribing controlled substances.

The above over-prescription practices can lead to the aggravation of prescription drug addiction.

A person may also gain access to prescription drugs via doctor shopping. "Doctor shopping" describes a practice in which a person searches for multiple sources of drugs by visiting different health practitioners and presenting a different list of complaints to each practitioner; the patient will then obtain multiple prescriptions and fill them at different pharmacies.

Society and Culture

Media and Activism

Prescription drug addiction is a major public health issue in the United States. According to the National Institute on Drug Abuse, approximately 2.7 million people met the criteria for a prescription opioid use disorder in 2021, and prescription opioids were involved in over 16,000 overdose deaths that year. This scale of harm demonstrates why public narratives – shaped by both media and activist communities – play such an important role in how society defines and responds to addiction.

Media Framing of Prescription Drug Addiction

Media organizations serve as powerful claims makers in defining prescription drug addiction as a social problem. A scoping review by Bosworth and colleagues examined sixteen studies of media portrayals of people with substance use disorders and found that coverage frequently depicted them as dangerous, criminal, or unstable, while only a small portion emphasized treatment or recovery. These portrayals reinforce stigma and shape public assumptions about the causes of addiction and the types of people affected by it.

Van Draanen and Erickson analyzed eighteen years of coverage in The Globe and Mail and found that early reporting relied heavily on criminal justice framing, using terms such as “misuse,” “abuse,” and “diversion.” However, as overdose deaths increased, the newspaper gradually incorporated more public-health language. This shift had political consequences: policymakers began referring to addiction using more structural explanations, including overprescribing, pharmaceutical marketing, and socioeconomic factors. Their findings show that media framing not only influences public understanding but also shapes the tone and content of policy discussions.

Kresovich and colleagues studied how partisan media consumption affects attitudes toward addiction policies. They found that stigma mediates the relationship between media consumption and policy support: people who frequently consume conservative media tend to develop stronger stigma toward people with opioid-use disorder, making them more likely to oppose harm-reduction measures such as naloxone distribution or supervised consumption sites. Meanwhile, individuals who consume more liberal media express lower stigma and stronger support for treatment-oriented policies. This demonstrates how the media’s influence is indirect—by shaping stigma, it also shapes public reaction and policy preferences.

Harm-Reduction Activists and Messaging Strategies

Harm-reduction advocates also participate in claims-making by crafting messages designed to reduce stigma and shift public understanding. White and colleagues interviewed fifteen U.S. harm-reduction advocates and found that data alone rarely persuades the public; instead, effective messaging must align with the values of the intended audience. For example, advocates emphasize community safety and reduced strain on emergency systems when speaking to law enforcement, while highlighting compassion and saving lives when speaking to families or faith groups.

The same study found that advocates frame harm reduction as part of a broader community solution, not merely a set of drug-related interventions. This framing encourages audiences to understand addiction as a shared social issue rather than an individual moral failing. By reshaping narratives around addiction, activists help counteract stigma and increase support for evidence-based policies such as syringe-service programs and medication-assisted treatment.

These communication strategies show that activists participate directly in defining addiction for the public. Their work complements the influence of the media by offering alternative narratives centered on health, safety, and community responsibility.

Stigma, Public Reaction, and Policy Development

Media framing and activist messaging together shape stigma, which then affects public reaction and policymaking. Strong stigma—reinforced by criminalizing or moralizing portrayals—reduces support for treatment-oriented policies and increases support for punitive approaches. Kresovich and colleagues found that stigma is the emotional mechanism that translates media exposure into policy attitudes: when stigma is high, support for evidence-based measures drops; when stigma is low, support increases.

Van Draanen and Erickson’s findings show that changes in media language can shift policymaker rhetoric, leading to more nuanced understandings of addiction and more willingness to consider structural explanations.³ Similarly, Netherland and Hansen demonstrate that when media portray addiction as a medical or social issue rather than as crime, public support grows for treatment and harm-reduction responses.

Through these processes, media and activist claims-making shape the entire trajectory of social responses to prescription drug addiction—from public understanding to political decisions and institutional outcomes.

Prescription drug addiction becomes understood as a social problem not only because of rising overdose rates but also because media and activists construct narratives about what addiction means and how society should respond. Media coverage has often emphasized crime and individual responsibility, reinforcing stigma and punitive approaches, while activists work to shift public narratives toward compassion, structural explanations, and evidence-based interventions. Together, these claims-making efforts influence stigma, public reaction, and policy development, revealing how the earliest stages of social-problem construction can shape long-term responses to addiction.

Sign in to keep reading

6 more chapters are free with a Lably account.

More in Health

Food and Drug AdministrationFederal agency of the United States Department of Health and Human ServicesCenters for Disease Control and PreventionUnited States government public health agencyNauseaMedical symptom or conditionSeizurePeriod of symptoms due to excessive or synchronous neuronal brain activityVomitingExpulsion of stomach contents via the mouth or noseIntravenous therapyMedication administered into a vein